Delivery Order SPE2DB20D1051-SPE2DB24FD8DN
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The award, valued at $5,155.20, is a firm-fixed-price contract with a performance period ending on May 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00, which serves as the primary vehicle for the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,038.12, is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens. It is a firm fixed-price, non-set-aside contract with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,546.59, is for the delivery of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed price and has a completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The $3,156 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,035.35, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the drug Mounjaro (generic name: tirzepatide) in a 15 mg/0.5 mL pen dosage form. The award, valued at $1,113.05, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and technical services to the U.S. Armed Forces. The contract is a firm-fixed price arrangement with a completion date of June 26, 2024....
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,342.28 contract is for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pen. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (Tirzepatide) 10 mg/0.5 mL pens. The contract has a firm fixed price, a ceiling value of $1,905.41, and a period of performance through April 2025. AmerisourceBergen, a for-profit organization headquartered in Conshohocken, Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,194.72, is for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 mL pen. The contract has a firm fixed-price, with a ceiling value of $3,818.40, and is set to expire on October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support various Department of Defense (DoD) and federal healthcare programs. This award is likely...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD8DNDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of the drug Mounjaro (Tirzepatide) 5 mg/0.5 ml pen. The contract has a firm fixed price of $2,593.98 and an ultimate completion date of May 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/28/24 |